Combination drug therapy

Latest research

1. Refining the clinical utility of [¹⁷⁷Lu]Lu/[²²⁵Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer

   • Liam Widjaja
   • Johannes Hornfeck
   • Rudolf A. Werner

   in European Journal of Nuclear Medicine and Molecular Imaging

   Article Open access 01 November 2025

   

2. The Expendables: Overlooked Medications with Anti-Cancer Properties

   • Anagha J. Deshpande
   • Javier Munoz
   • Razelle Kurzrock

   in Current Oncology Reports

   Article 01 November 2025

   

3. Effectiveness of a Collaborative Deprescribing Intervention of Proton Pump Inhibitors on Community-Dwelling Older Adults: The C-SENIoR Pragmatic Non-randomised Controlled Trial

   • Sónia Romano
   • António Teixeira Rodrigues
   • Julian Perelman

   in Drugs & Aging

   Article Open access 01 November 2025

   

4. The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysis

   • Kota Tokunaga
   • Yu Fujiwara
   • Sarbajit Mukherjee

   in Targeted Oncology

   Article Open access 01 November 2025

   

5. The Role of Dexketoprofen/Tramadol in Multimodal Therapy to Prevent Acute Postsurgical and Acute Low Back Pain from Developing into Chronic Pain: A Delphi Consensus Study

   • Giustino Varrassi
   • Maria Dolma Gudez-Santos
   • Ignas Zasimavičius

   in Pain and Therapy

   Article Open access 01 November 2025

   

6. Arterieller Lungenhochdruck: Kombitherapie macht Punkte

   • Dirk Skowasch

   in MMW - Fortschritte der Medizin

   Article 31 October 2025

   

7. Efficacy and safety of DEB-TACE combined with HAIC and donafenib in the treatment of unresectable hepatocellular carcinoma: a dual-center retrospective study

   • Xuexian Zhang
   • Xinyi Fang
   • Shangbo Shi

   in BMC Cancer

   Article Open access 31 October 2025

   

8. How Do We Increase Treatment for Alcohol Use Disorder in Primary Care? It Takes a Team

   • Jacob Weiss
   • Tyler Varisco
   • Jarratt D. Pytell

   in Journal of General Internal Medicine

   Article 31 October 2025

9. Parkinson’s disease, aerobic exercise and photobiomodulation: a randomised controlled trial

   • Luis Santos
   • Johannes Burtscher
   • Luis de Taboada

   in Journal of Neural Transmission

   Article 31 October 2025

   

10. High-concentration doxorubicin in cTACE: a retrospective cohort study of efficacy and safety

    • Siobhan Lee
    • Elliot Lee
    • Christian Abel

    in CVIR Oncology

    Article Open access 31 October 2025

    

11. Updated cost-effectiveness analysis of first-line novel therapies in locally advanced or metastatic urothelial carcinoma across the UK, US, and China

    • Jingwen Lin
    • Wu Fu
    • Hongfu Cai

    in World Journal of Urology

    Article 31 October 2025

    

12. Advancing Medulloblastoma Treatment: Molecular Mechanisms, Drug Repurposing, and Precision Therapies

    • Mohammed A. Abdel-Rasol
    • Wael M. El-Sayed

    in Molecular Diagnosis & Therapy

    Article Open access 31 October 2025

    

13. The Intervention Effects of Blended Cognitive Behavioral Therapy on Patients with Depression: A Meta-analysis

    • Jiajun Lan
    • Zhikai Qin
    • Junsheng Wang

    in Cognitive Therapy and Research

    Article 31 October 2025

    

14. Oral therapies for unfit patients with acute myeloid leukemia

    • Verena Petzer

    in memo - Magazine of European Medical Oncology

    Article Open access 30 October 2025

15. Synergistic effects of colistin-based combinations against colistin and carbapenem-resistant Klebsiella pneumoniae isolated from nosocomial bloodstream infections

    • Bahman Pourabbas
    • Shima Sepehrpour
    • Zahra Rezaei

    in Scientific Reports

    Article Open access 30 October 2025

    

16. Risk of severe infections in patients with triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel: a real-world, postmarketing database study in Japan

    • Akinori Yuri
    • Sayuri Nakane
    • Ayako Murayama

    in International Journal of Clinical Oncology

    Article Open access 30 October 2025

    

17. Home-based treatment for patients with hematological cancer in Denmark–A national overview

    • Kristina Holmegaard Nørskov
    • Hanne Bødtcher
    • Susanne Oksbjerg Dalton

    in Supportive Care in Cancer

    Article Open access 30 October 2025

    

18. MDG-DDI: multi-feature drug graph for drug-drug interaction prediction

    • Wenjun Li
    • Yiting Zhou
    • Xiwei Tang

    in BMC Bioinformatics

    Article Open access 30 October 2025

    

19. The interplay between hepatitis B virus and antitumor drugs in the treatment of hepatocellular carcinoma

    • Tianyu Ma
    • Feilong Zhao
    • Ruyu Liu

    in Clinical and Experimental Medicine

    Article Open access 29 October 2025

    

20. Integrative network pharmacology and experimental validation of multi-target synergy against multidrug-resistant klebsiella pneumoniae via PI3K/AKT-MAPK pathway disruption

    • Tian Man
    • Huiyong Yu
    • Chengxiang Wang

    in Naunyn-Schmiedeberg's Archives of Pharmacology

    Article 29 October 2025

    

Related journals

• 

  Journal

  Cancer Chemotherapy and Pharmacology

  Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an...

  Publishing model

  Hybrid

  Journal Impact Factor

  2.3 (2024)

  Downloads

  808,308 (2024)

  Submission to first decision(median)

  4 days

• 

  Journal

  Reactions Weekly

  Reactions Weeklyis the unique one-stop-shop for all your adverse drug event needs, bringing you up-to-the minute summaries of the world's adverse...

  Publishing model

  Subscription

  Downloads

  904,085 (2024)

• 

  Journal

  Investigational New Drugs

  The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugsprovides a forum...

  Publishing model

  Hybrid

  Journal Impact Factor

  2.7 (2024)

  Downloads

  461,783 (2024)

  Submission to first decision(median)

  5 days